Brokkoli bei Pankreaskarzinom – welche Dosis?

Lozanovski VJ, Polychronidis G, Gross W et al. Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects – results from the POUDER pilot study. Invest New Drugs 2019. doi:10.1007/s10637-019-00826-z

• Literatur

• 7 Doehmer J, Eisenbraun J. Assessment of extracts from mistletoe (Viscum album) for herb–drug interaction by inhibition and induction of cytochrome P450 activities. Phytother Res 2012; 26: 11-17 doi:10.1002/ptr.3473
• 8 Weissenstein U, Kunz M, Oufir M. et al. Absence of herb-drug interactions of mistletoe with the tamoxifen metabolite (E/Z)-endoxifen and cytochrome P450 3A4/5 and 2D6 in vitro. BMC Complement Altern Med 2019; 19: 23 doi:10.1186/s12906-019-2439-2
• 9 Thronicke A, Steele ML, Grah C. et al. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer. BMC Complement Altern Med 2017; 17: 534 doi:10.1186/s12906-017-2045-0
• Schad F, Axtner J, Kröz M. et al. Safety of combined treatment with monoclonal antibodies and Viscum album L preparations. Integrative Cancer Therapies 2018; 17: 41-51 doi:10.1177/1534735416681641